SlideShare a Scribd company logo
1 of 26
Biotec Services International
John Shaw
john.shaw@biotec-uk.com
Business Development Manager


Paul Viggers
paul.viggers@biotec-uk.com
Business Development Manager


Sarah Coram
sarah.coram@biotec-uk.com
Business Development Manager
Who are Biotec?
Your company of choice for temperature controlled pharmaceutical services. Through
experience gained from over 15 years in the clinical supply arena, Biotec have
assembled a team of dedicated professionals to ensure that every project we manage on
your behalf is ‘In Safe Hands’ from initiation to completion.

Background
•   Founded in 1997
•   Privately owned
•   Split-site, purpose built GMP facilities licensed by the MHRA
•   Queen’s Award for Enterprise 2009
Product Experience
Classification               Product type
Biologics                    Monoclonal antibodies
                             Therapeutic proteins
                             Vaccines
                             Viruses
Advanced Therapy Medicinal   Stem cells
Products                     Gene therapies (GMO Biosafety level 2)
                             Tissue engineered products
Small molecules              Oral
                             Injectable
                             Topical
                             Inhalation
Controlled drugs             Schedules 2 to 4
Devices                      Patient use
                             Surgical use
QP & GMP Consultancy
•   Seven QPs with wide experience of Biotec’s core service areas

•   Advice to ensure speedy transition through regulatory hurdles utilizing
    Biotec’s unique ‘Product Supply Route Map’

•   QP audits & familiarisation visits for IMP and Marketed Product importation
    providing a smooth path to release

•   Expert knowledge regarding:
    • EU regulatory requirements
    • Label text compliance
    • Blinding issues
Clinical Supplies
•   Comprehensive clinical trials supply service by combining:
    • In-house capabilities and expertise
    • Services of expert partners where appropriate

•   Currently serve over 35 clients with one or more clinical
    projects – Phase I to III

•   Global supply
    • Customer base spanning from West Coast USA to Asia
      Pacific
    • Staff adept at handling multi-national, multi-cultural
      trials
Clinical Supplies
•   Management of unlicensed medicines through Biotec’s Specials supply service
    • Manufacturers Specials Licence MS/19819
    • Continuation of supply to patients for compassionate use

•   Biotec’s experienced Project Management team advantage
    • An average of 14 years industry experience
    • Extensive knowledge of handling challenging products and clinical trials
    • A flexible approach to reporting activities – tailored to client requirements
    • Established team who strive to develop the relationship and stay with the client
      throughout future projects
Global Logistics
•   Expert logistics team take control to reduce risk to client, patient and product
    • Handle shipping declarations and import/export documentation
    • Site specific advice available via ‘In Safe Hands’ video and proactive
      communication

•   Qualified shipping systems from ambient temperature to vapour phase nitrogen
    • Vast experience in handling ultra low temperature materials
    • Product specific qualification of shippers & transport systems if required

•   Range of temperature monitoring options available to meet specific requirements

•   Utilisation of partner depot network for global supply
    • 23 depots in key geographical locations
Global Logistics
GMP Temperature Controlled
Storage
•   Proven track record of successful long term storage for
    biologicals (up to Biosafety level 2), controlled drugs
    (Schedule 2 to 4), clinical and retain materials

•   Flexible approach to storage offering single sample
    through to pallet size options at a range of temperatures

•   Dual site storage managed via one point of contact

•   ‘Rapid Response Service’ - reactive to expedited
    shipment requests to ensure that material is transferred
    rapidly
Advanced Therapy Medicinal
Products
•   Over 10 years experience handling ATMPs
•   Proven track record handling ultra low temperature
    material
•   Technical support team to advise on specific product
    handling options
•   Constant review of new technology to improve
    Biotec’s service offering
Commercial Services
•   Managed through Biotec’s wholesaler Dealers licence

•   Commercial supply activities segregated from clinical projects

•   Strategy is to focus on niche products
    • Hospital supply
    • Orphan drugs
    • Difficult to handle, temperature sensitive products

•   Expedited dispatch and global market delivery
The Biotec Approach
….at Biotec          Strategy
Communication        Committed team who understand the clients needs
                     Low staff turnover – retention of client preferences
                     Flexible team to ensure all clients are offered a premium service
Project Management   Dedicated Project Manager assigned to each customer
                     First point of call for queries
                     Work in partnership to achieve project goals
Expertise            Experienced management, operational and Quality teams
                     Large proportion of repeat business from a global client base
                     Extensive experience with difficult to handle products
Forward Thinking     Investment to meet client needs
                     Focus on continuous improvement
Biotec Facilities (Capacity)

   Capacity                      Biotec House          Biotec 2
   Facility size                 14,000 ft2            10,000 ft2
   General warehousing           86 pallets            30 pallets
   Controlled ambient            26 pallets            150 pallets
   2-8°C                         20 pallets            80 pallets plus
                                                       20,000 kits
   -20°C                         800 kits              50 pallets 2,000 kits
   -80°C                         340,000 vial          -
                                 locations
   Liquid/vapour phase nitrogen 27 x 40 litre dewars   -
Regulatory History
•   Inspected by MHRA every two years since 2004 with the
    adoption of the EU clinical trials directive 2001/20/EC
    • No critical or major observations during this time
    • Next inspection planned for May 2012

•   Biotec possess the following licences
    • MIA 19819
    • MIA(IMP) 19819
    • Manufacturers Specials Licence MS/19819

•   Also inspected annually by BMTRADA for verification of
    compliance to ISO9001:2008

•   Regular client audits averaging two per month
Clinical Supplies
•   Protocol interpretation for kit design and supply strategy
•   IVR and IWR controlled studies
•   Randomisation schedules and decode options
•   Sourcing of comparators and ancillary products
•   Label and leaflet design, translation and printing
•   Primary packing
•   Patient Pack assembly
•   Global distribution
•   Expiry date extension
•   Returns, reconciliation and destruction
Global Logistics
•   Shipment temperatures supported
     • +15ºC to +25ºC
     • +2ºC to +8ºC
     • -15ºC to -25ºC
     • -60ºC to -80ºC
     • -140ºC (dry shipper)
GMP Temperature Controlled
Storage
•   Storage temperatures supported
     • +15ºC to +25ºC
     • +2ºC to +8ºC
     • -15ºC to -25ºC
     • -80ºC
     • Vapour phase N2 (-140ºC)
     • Liquid N2 (-196ºC)

More Related Content

What's hot

Advanced Cell Therapies - GMP Manufacturing
Advanced Cell Therapies - GMP Manufacturing Advanced Cell Therapies - GMP Manufacturing
Advanced Cell Therapies - GMP Manufacturing Comecer
 
Communication of Bio-based content
Communication of Bio-based contentCommunication of Bio-based content
Communication of Bio-based contentHarmen Willemse
 
Solutions for Packaging and Food Industry
Solutions for Packaging and Food IndustrySolutions for Packaging and Food Industry
Solutions for Packaging and Food IndustryMartin Kurz
 
What is New in Track and Trace Technology?
What is New in Track and Trace Technology?What is New in Track and Trace Technology?
What is New in Track and Trace Technology?Angela Carver
 
Food Recalls: Effective Supplier - Retailer Partnerships
Food Recalls: Effective Supplier - Retailer PartnershipsFood Recalls: Effective Supplier - Retailer Partnerships
Food Recalls: Effective Supplier - Retailer PartnershipsAlchemy Systems
 
Warehousing & Material management
Warehousing & Material managementWarehousing & Material management
Warehousing & Material managementTeny Thomas
 
InstantGMP Cmpliance Series - Packaging and Labeling
InstantGMP Cmpliance Series - Packaging and LabelingInstantGMP Cmpliance Series - Packaging and Labeling
InstantGMP Cmpliance Series - Packaging and LabelingInstantGMP™
 
Good ware house practice
Good ware house practice Good ware house practice
Good ware house practice Tahiya Tabassum
 
GMP of ASU Drugs
GMP of ASU DrugsGMP of ASU Drugs
GMP of ASU DrugsAkhtar Ali
 
Presentation - G Howlett - BRC Issue 6 Seminar
Presentation - G Howlett - BRC Issue 6 SeminarPresentation - G Howlett - BRC Issue 6 Seminar
Presentation - G Howlett - BRC Issue 6 Seminarsafefood360
 
Regulating the manufacture of therapeutic goods
Regulating the manufacture of therapeutic goodsRegulating the manufacture of therapeutic goods
Regulating the manufacture of therapeutic goodsTGA Australia
 
Hand Sanitiser Production Facility
Hand Sanitiser Production FacilityHand Sanitiser Production Facility
Hand Sanitiser Production FacilityGeertje van Keulen
 
BRITISH RETAIL CONSORTIUM
BRITISH RETAIL CONSORTIUM BRITISH RETAIL CONSORTIUM
BRITISH RETAIL CONSORTIUM Vimal kumar
 
Good Manufacturing Practices
Good Manufacturing PracticesGood Manufacturing Practices
Good Manufacturing PracticesUmesh Bhandari
 

What's hot (17)

Advanced Cell Therapies - GMP Manufacturing
Advanced Cell Therapies - GMP Manufacturing Advanced Cell Therapies - GMP Manufacturing
Advanced Cell Therapies - GMP Manufacturing
 
Communication of Bio-based content
Communication of Bio-based contentCommunication of Bio-based content
Communication of Bio-based content
 
Solutions for Packaging and Food Industry
Solutions for Packaging and Food IndustrySolutions for Packaging and Food Industry
Solutions for Packaging and Food Industry
 
Challenges of Cold Chain Supply
Challenges of Cold Chain SupplyChallenges of Cold Chain Supply
Challenges of Cold Chain Supply
 
What is New in Track and Trace Technology?
What is New in Track and Trace Technology?What is New in Track and Trace Technology?
What is New in Track and Trace Technology?
 
Food Recalls: Effective Supplier - Retailer Partnerships
Food Recalls: Effective Supplier - Retailer PartnershipsFood Recalls: Effective Supplier - Retailer Partnerships
Food Recalls: Effective Supplier - Retailer Partnerships
 
Warehousing & Material management
Warehousing & Material managementWarehousing & Material management
Warehousing & Material management
 
1.c gmp as per schedule m
1.c gmp as per schedule m 1.c gmp as per schedule m
1.c gmp as per schedule m
 
InstantGMP Cmpliance Series - Packaging and Labeling
InstantGMP Cmpliance Series - Packaging and LabelingInstantGMP Cmpliance Series - Packaging and Labeling
InstantGMP Cmpliance Series - Packaging and Labeling
 
Good ware house practice
Good ware house practice Good ware house practice
Good ware house practice
 
GMP of ASU Drugs
GMP of ASU DrugsGMP of ASU Drugs
GMP of ASU Drugs
 
Presentation - G Howlett - BRC Issue 6 Seminar
Presentation - G Howlett - BRC Issue 6 SeminarPresentation - G Howlett - BRC Issue 6 Seminar
Presentation - G Howlett - BRC Issue 6 Seminar
 
Regulating the manufacture of therapeutic goods
Regulating the manufacture of therapeutic goodsRegulating the manufacture of therapeutic goods
Regulating the manufacture of therapeutic goods
 
Hand Sanitiser Production Facility
Hand Sanitiser Production FacilityHand Sanitiser Production Facility
Hand Sanitiser Production Facility
 
BRC FOOD v2
BRC FOOD v2BRC FOOD v2
BRC FOOD v2
 
BRITISH RETAIL CONSORTIUM
BRITISH RETAIL CONSORTIUM BRITISH RETAIL CONSORTIUM
BRITISH RETAIL CONSORTIUM
 
Good Manufacturing Practices
Good Manufacturing PracticesGood Manufacturing Practices
Good Manufacturing Practices
 

Viewers also liked

Carbon-14 labelled ADCs and Peptides by Sean L Kitson
Carbon-14 labelled ADCs and Peptides by Sean L KitsonCarbon-14 labelled ADCs and Peptides by Sean L Kitson
Carbon-14 labelled ADCs and Peptides by Sean L Kitsonseankitson
 
Antibody drug conjugates for cancer
Antibody drug conjugates for cancerAntibody drug conjugates for cancer
Antibody drug conjugates for cancerAnvita Bharati
 
Biotech Start-Up Management Overview PPT
Biotech Start-Up Management Overview PPTBiotech Start-Up Management Overview PPT
Biotech Start-Up Management Overview PPTJuhani Lahdenperä
 
Business Plan on a Bio-Tech product
Business Plan on a Bio-Tech productBusiness Plan on a Bio-Tech product
Business Plan on a Bio-Tech productTarkeshwar Singh
 

Viewers also liked (7)

Antibody Drug Conjugates
Antibody Drug ConjugatesAntibody Drug Conjugates
Antibody Drug Conjugates
 
Carbon-14 labelled ADCs and Peptides by Sean L Kitson
Carbon-14 labelled ADCs and Peptides by Sean L KitsonCarbon-14 labelled ADCs and Peptides by Sean L Kitson
Carbon-14 labelled ADCs and Peptides by Sean L Kitson
 
Antibody drug conjugates for cancer
Antibody drug conjugates for cancerAntibody drug conjugates for cancer
Antibody drug conjugates for cancer
 
Biotech Start-Up Management Overview PPT
Biotech Start-Up Management Overview PPTBiotech Start-Up Management Overview PPT
Biotech Start-Up Management Overview PPT
 
Business Plan on a Bio-Tech product
Business Plan on a Bio-Tech productBusiness Plan on a Bio-Tech product
Business Plan on a Bio-Tech product
 
Biotechnology
BiotechnologyBiotechnology
Biotechnology
 
E sci presentation
E sci presentationE sci presentation
E sci presentation
 

Similar to Biotec Services International: Your Company of Choice for Temperature Controlled Pharmaceutical Services

Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Ravs100
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012tony_street
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012biotec_fiona
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Ravs100
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedinbiotec_rachel
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation LinkedinMatthewLakelin
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedinbiotec_fiona
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedinbiotec_paul
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedinbiotec_amanda
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation LinkedinRavs100
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedintrisevans
 
Bilcare gcs leaflet
Bilcare gcs leafletBilcare gcs leaflet
Bilcare gcs leafletBilcareltd
 
Understanding and Controlling Bioprocess Variation | Parker domnick hunter
Understanding and Controlling Bioprocess Variation | Parker domnick hunterUnderstanding and Controlling Bioprocess Variation | Parker domnick hunter
Understanding and Controlling Bioprocess Variation | Parker domnick hunterParker Hannifin Corporation
 
Recipharm Development Services May 2015
Recipharm Development Services May 2015Recipharm Development Services May 2015
Recipharm Development Services May 2015Sylvia Kachalsky
 
Supplier selection process of Merk
Supplier selection process of MerkSupplier selection process of Merk
Supplier selection process of MerkSana Fatima
 
Cavalier Pharma Logistics Group Capabilities & IQP Overview winyard2015
Cavalier Pharma Logistics Group Capabilities & IQP  Overview winyard2015Cavalier Pharma Logistics Group Capabilities & IQP  Overview winyard2015
Cavalier Pharma Logistics Group Capabilities & IQP Overview winyard2015Stephen D. Winyard
 

Similar to Biotec Services International: Your Company of Choice for Temperature Controlled Pharmaceutical Services (20)

Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012
 
Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012Biotec Presentation 27 March 2012
Biotec Presentation 27 March 2012
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
Biotec Presentation Linkedin
Biotec Presentation LinkedinBiotec Presentation Linkedin
Biotec Presentation Linkedin
 
PharmaSynth Biopharmaceutical Manufacturing Services
PharmaSynth Biopharmaceutical Manufacturing ServicesPharmaSynth Biopharmaceutical Manufacturing Services
PharmaSynth Biopharmaceutical Manufacturing Services
 
Stabicon-Corporate presentation
Stabicon-Corporate presentationStabicon-Corporate presentation
Stabicon-Corporate presentation
 
Bilcare gcs leaflet
Bilcare gcs leafletBilcare gcs leaflet
Bilcare gcs leaflet
 
Understanding and Controlling Bioprocess Variation | Parker domnick hunter
Understanding and Controlling Bioprocess Variation | Parker domnick hunterUnderstanding and Controlling Bioprocess Variation | Parker domnick hunter
Understanding and Controlling Bioprocess Variation | Parker domnick hunter
 
Recipharm Development Services May 2015
Recipharm Development Services May 2015Recipharm Development Services May 2015
Recipharm Development Services May 2015
 
Supplier selection process of Merk
Supplier selection process of MerkSupplier selection process of Merk
Supplier selection process of Merk
 
Stabicon Corporate Presentation
Stabicon Corporate PresentationStabicon Corporate Presentation
Stabicon Corporate Presentation
 
Cavalier Pharma Logistics Group Capabilities & IQP Overview winyard2015
Cavalier Pharma Logistics Group Capabilities & IQP  Overview winyard2015Cavalier Pharma Logistics Group Capabilities & IQP  Overview winyard2015
Cavalier Pharma Logistics Group Capabilities & IQP Overview winyard2015
 
Meditech surgical
Meditech surgicalMeditech surgical
Meditech surgical
 

Biotec Services International: Your Company of Choice for Temperature Controlled Pharmaceutical Services

  • 1.
  • 2. Biotec Services International John Shaw john.shaw@biotec-uk.com Business Development Manager Paul Viggers paul.viggers@biotec-uk.com Business Development Manager Sarah Coram sarah.coram@biotec-uk.com Business Development Manager
  • 3. Who are Biotec? Your company of choice for temperature controlled pharmaceutical services. Through experience gained from over 15 years in the clinical supply arena, Biotec have assembled a team of dedicated professionals to ensure that every project we manage on your behalf is ‘In Safe Hands’ from initiation to completion. Background • Founded in 1997 • Privately owned • Split-site, purpose built GMP facilities licensed by the MHRA • Queen’s Award for Enterprise 2009
  • 4. Product Experience Classification Product type Biologics Monoclonal antibodies Therapeutic proteins Vaccines Viruses Advanced Therapy Medicinal Stem cells Products Gene therapies (GMO Biosafety level 2) Tissue engineered products Small molecules Oral Injectable Topical Inhalation Controlled drugs Schedules 2 to 4 Devices Patient use Surgical use
  • 5.
  • 6.
  • 7. QP & GMP Consultancy • Seven QPs with wide experience of Biotec’s core service areas • Advice to ensure speedy transition through regulatory hurdles utilizing Biotec’s unique ‘Product Supply Route Map’ • QP audits & familiarisation visits for IMP and Marketed Product importation providing a smooth path to release • Expert knowledge regarding: • EU regulatory requirements • Label text compliance • Blinding issues
  • 8.
  • 9. Clinical Supplies • Comprehensive clinical trials supply service by combining: • In-house capabilities and expertise • Services of expert partners where appropriate • Currently serve over 35 clients with one or more clinical projects – Phase I to III • Global supply • Customer base spanning from West Coast USA to Asia Pacific • Staff adept at handling multi-national, multi-cultural trials
  • 10. Clinical Supplies • Management of unlicensed medicines through Biotec’s Specials supply service • Manufacturers Specials Licence MS/19819 • Continuation of supply to patients for compassionate use • Biotec’s experienced Project Management team advantage • An average of 14 years industry experience • Extensive knowledge of handling challenging products and clinical trials • A flexible approach to reporting activities – tailored to client requirements • Established team who strive to develop the relationship and stay with the client throughout future projects
  • 11.
  • 12. Global Logistics • Expert logistics team take control to reduce risk to client, patient and product • Handle shipping declarations and import/export documentation • Site specific advice available via ‘In Safe Hands’ video and proactive communication • Qualified shipping systems from ambient temperature to vapour phase nitrogen • Vast experience in handling ultra low temperature materials • Product specific qualification of shippers & transport systems if required • Range of temperature monitoring options available to meet specific requirements • Utilisation of partner depot network for global supply • 23 depots in key geographical locations
  • 14.
  • 15. GMP Temperature Controlled Storage • Proven track record of successful long term storage for biologicals (up to Biosafety level 2), controlled drugs (Schedule 2 to 4), clinical and retain materials • Flexible approach to storage offering single sample through to pallet size options at a range of temperatures • Dual site storage managed via one point of contact • ‘Rapid Response Service’ - reactive to expedited shipment requests to ensure that material is transferred rapidly
  • 16.
  • 17. Advanced Therapy Medicinal Products • Over 10 years experience handling ATMPs • Proven track record handling ultra low temperature material • Technical support team to advise on specific product handling options • Constant review of new technology to improve Biotec’s service offering
  • 18.
  • 19. Commercial Services • Managed through Biotec’s wholesaler Dealers licence • Commercial supply activities segregated from clinical projects • Strategy is to focus on niche products • Hospital supply • Orphan drugs • Difficult to handle, temperature sensitive products • Expedited dispatch and global market delivery
  • 20. The Biotec Approach ….at Biotec Strategy Communication Committed team who understand the clients needs Low staff turnover – retention of client preferences Flexible team to ensure all clients are offered a premium service Project Management Dedicated Project Manager assigned to each customer First point of call for queries Work in partnership to achieve project goals Expertise Experienced management, operational and Quality teams Large proportion of repeat business from a global client base Extensive experience with difficult to handle products Forward Thinking Investment to meet client needs Focus on continuous improvement
  • 21.
  • 22. Biotec Facilities (Capacity) Capacity Biotec House Biotec 2 Facility size 14,000 ft2 10,000 ft2 General warehousing 86 pallets 30 pallets Controlled ambient 26 pallets 150 pallets 2-8°C 20 pallets 80 pallets plus 20,000 kits -20°C 800 kits 50 pallets 2,000 kits -80°C 340,000 vial - locations Liquid/vapour phase nitrogen 27 x 40 litre dewars -
  • 23. Regulatory History • Inspected by MHRA every two years since 2004 with the adoption of the EU clinical trials directive 2001/20/EC • No critical or major observations during this time • Next inspection planned for May 2012 • Biotec possess the following licences • MIA 19819 • MIA(IMP) 19819 • Manufacturers Specials Licence MS/19819 • Also inspected annually by BMTRADA for verification of compliance to ISO9001:2008 • Regular client audits averaging two per month
  • 24. Clinical Supplies • Protocol interpretation for kit design and supply strategy • IVR and IWR controlled studies • Randomisation schedules and decode options • Sourcing of comparators and ancillary products • Label and leaflet design, translation and printing • Primary packing • Patient Pack assembly • Global distribution • Expiry date extension • Returns, reconciliation and destruction
  • 25. Global Logistics • Shipment temperatures supported • +15ºC to +25ºC • +2ºC to +8ºC • -15ºC to -25ºC • -60ºC to -80ºC • -140ºC (dry shipper)
  • 26. GMP Temperature Controlled Storage • Storage temperatures supported • +15ºC to +25ºC • +2ºC to +8ºC • -15ºC to -25ºC • -80ºC • Vapour phase N2 (-140ºC) • Liquid N2 (-196ºC)